You just read:

Global Acute Coronary Syndrome Drug Forecast and Market Analysis to 2025: Novel Lipid Altering Therapies will Steer Acute Coronary Syndrome Market Beyond $12 Billion by 2022 - Research and Markets

News provided by

Research and Markets

27 Jan, 2017, 13:10 ET